Historical pm News Stories
Philip Morris Q1 Gains; Japan Tax Headwinds, PM Q2
Recent concrete developments — a white paper that pressured shares, solid Q1 2026 revenue and heated-tobacco growth, and scheduled Japanese excise-tax hikes — create measurable near-term headwinds for Philip Morris (PM) while underscoring the company’s long-term smoke-free transition.
PM Stock Slumps After FDA Delays ZYN Ultra Rollout
Philip Morris shares plunged after the FDA delayed approval of ZYN Ultra, triggering a one-day drop near 6% and amplifying concerns about the company’s smoke-free growth trajectory. Analysts remain cautiously optimistic, but near-term regulatory and competitive pressures have increased investor scrutiny.
Philip Morris: Smoke-Free Gains, Japan Tax Risk
Philip Morris reported strong smoke-free growth—EPS up double digits and smoke-free products now over 41% of revenue—but near-term headwinds from Japan excise hikes and ZYN inventory normalization could pressure PM stock in the S&P 500.
Philip Morris PM: Smoke-Free Growth vs BAT's Velo!
Philip Morris reported strong smoke-free revenue and margin expansion while British American Tobacco's Velo posted a sharp U.S. sales surge. Elevated trading volumes and recent guidance make PM stock sensitive to competitive and regulatory catalysts — here are the key facts and investor takeaways from the past week.
Philip Morris: Smoke-Free Surge Powers Q4 Beat Now
Philip Morris delivered stronger-than-expected Q4 and full-year results driven by rapid adoption of smoke-free products, while regulatory progress on ZYN and persistent cost pressures will be key near-term catalysts for PM stock.